Literature DB >> 3875907

Urgent relaparotomy: the high-risk, no-choice operation.

T J Bunt.   

Abstract

Two thousand six hundred fifty-seven primary laparotomies were performed during a 50-month period; 192 (7%) of these were relaparotomies within 21 days for complications of primary laparotomy. The overall mortality rate was 36% (69/192). Relaparotomy for dehiscence (0/15) or obstruction (5%-1/21) carried little risk and for abscess a moderate risk (13%-6/47). Relaparotomy for gastrointestinal or intraperitoneal hemorrhage entailed higher risks at 44% (4/9) and 27% (6/22), respectively. Age was a significant determinant of mortality, being 16% (13/82) for less than 50 years of age but 50% (56/110) for greater than 50 years (p less than 0.001). The major determinant at all age groups was sepsis, varying from 50% (4/8) for patients less than 50 years to 89% (34/38) for patients greater than 50 years (p less than 0.01). Differentiation was made between localized intra-abdominal infection (IAS-1) and nonlocalized/systemic infection (IAS-2): the mortality rate for 47 patients with IAS-1 was 13% and for IAS-2 83% (p less than 0.001). Urgent relaparotomy is necessary and may be performed safely for incisional dehiscence, obstruction, or IAS-1, with low mortality and high patient salvage rates. Directed relaparotomy for IAS-2 carries a high mortality rate but is the only means of patient salvage. Nondirected relaparotomy for multiple system and organ failure alone without supportive clinical or radiologic findings was futile, with a 13% (2/15) rate of positive exploration (p less than 0.001) and no patient salvage.

Entities:  

Mesh:

Year:  1985        PMID: 3875907

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Surgical hemorrhage, damage control, and the abdominal compartment syndrome.

Authors:  Kerry L Hammond; David A Margolin
Journal:  Clin Colon Rectal Surg       Date:  2006-11

2.  Preoperative risk factors for mortality after relaparotomy: analysis of 254 patients.

Authors:  Isidro Martínez-Casas; Juan J Sancho; Esther Nve; Maria-José Pons; Estela Membrilla; Luis Grande
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

3.  Intra-abdominal sepsis.

Authors:  R C Russell
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

4.  Is repeat laparotomy of value in patients with suspected intra-abdominal sepsis in the intensive care unit?

Authors:  C McCrory; K Crowley
Journal:  Ir J Med Sci       Date:  1997 Apr-Jun       Impact factor: 1.568

Review 5.  Clinical predictors of ongoing infection in secondary peritonitis: systematic review.

Authors:  Bas Lamme; Cecilia W Mahler; Oddeke van Ruler; Dirk J Gouma; Johannes B Reitsma; Marja A Boermeester
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

6.  Complication rates among trauma centers.

Authors:  Darwin N Ang; Frederick P Rivara; Avery Nathens; Gregory J Jurkovich; Ronald V Maier; Jin Wang; Ellen J MacKenzie
Journal:  J Am Coll Surg       Date:  2009-09-19       Impact factor: 6.113

7.  Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery.

Authors:  Robert R Hutchins; M Paul Gunning; D Nuala Lucas; Timothy G Allen-Mersh; Neil C Soni
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

8.  Relaparotomies: Why is Mortality Higher?

Authors:  Ercan Gedik; Kazým Söylemez; Sadullah Girgin; Ersin Uysal; Ýbrahim Taçyýldýz
Journal:  Eur J Trauma Emerg Surg       Date:  2009-05-12       Impact factor: 3.693

9.  Postoperative peritonitis without an underlying digestive fistula after complete cytoreductive surgery plus HIPEC.

Authors:  Charles Honoré; Isabelle Sourrouille; Stéphanie Suria; Ludivine Chalumeau-Lemoine; Frédéric Dumont; Diane Goéré; Dominique Elias
Journal:  Saudi J Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 2.485

10.  [Study of early relaparotomies at the University Hospitals of Lubumbashi: epidemiological clinical and therapeutic features].

Authors:  Catherine Saleh Ugumba; Marc Kashal Kasong; Cedrick Sangwa Milindi; Gabriel Wakunga Warach; François Tshilombo Katombe; Etienne Odimba Bfkoshe
Journal:  Pan Afr Med J       Date:  2018-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.